Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Phreesia and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Phreesia securities between May 8, 2025 and March 30, 2026. The complaint claims the company made false and misleading statements and failed to disclose slowing demand, diminished visibility into key revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors have until July 13, 2026 to seek lead plaintiff appointment. The law firm represents investors on a contingency fee basis.
Phreesia IncClass action lawsuit alleging securities fraud and failure to disclose slowing demand and weakened revenue visibility.